|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-6-14
|
|
pubmed:abstractText |
It has been reported that a docetaxel-carboplatin combination as first-line chemotherapy for ovarian cancer showed a level of progression-free survival similar to that of paclitaxel-carboplatin while reducing neurotoxicity and improving quality of life. We investigated the recommended doses of docetaxel-carboplatin in Japanese patients with ovarian cancer and conducted a comparative study of docetaxel-carboplatin versus paclitaxel-carboplatin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1341-9625
|
|
pubmed:author |
pubmed-author:FujitaHiroyukiH,
pubmed-author:HonjoHideoH,
pubmed-author:HosokawaKenichiK,
pubmed-author:KatoYoshikoY,
pubmed-author:KinoshitaYoshiyukiY,
pubmed-author:KuroboshiHaruoH,
pubmed-author:MoriTaisukeT,
pubmed-author:NakataYoshinoriY,
pubmed-author:WatanabeAiA,
pubmed-author:YamaguchiTakeshiT,
pubmed-author:YasudaJinsukeJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
205-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17566844-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17566844-Carboplatin,
pubmed-meshheading:17566844-Drug Toxicity,
pubmed-meshheading:17566844-Female,
pubmed-meshheading:17566844-Humans,
pubmed-meshheading:17566844-Japan,
pubmed-meshheading:17566844-Maximum Tolerated Dose,
pubmed-meshheading:17566844-Middle Aged,
pubmed-meshheading:17566844-Multivariate Analysis,
pubmed-meshheading:17566844-Ovarian Neoplasms,
pubmed-meshheading:17566844-Paclitaxel,
pubmed-meshheading:17566844-Pilot Projects,
pubmed-meshheading:17566844-Quality of Life,
pubmed-meshheading:17566844-Survival Analysis,
pubmed-meshheading:17566844-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
